Automated description from the Alliance of Genome Resources (Release 7.4.0)
Enables DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates; DNA binding activity; and lncRNA binding activity. Involved in negative regulation of gene expression, epigenetic. Acts upstream of or within several processes, including cellular response to amino acid stimulus; epigenetic regulation of gene expression; and negative regulation of transcription by RNA polymerase II. Located in chromosome, centromeric region; heterochromatin; and nucleus. Is expressed in several structures, including alimentary system; brain; early conceptus; genitourinary system; and hemolymphoid system. Used to study immunodeficiency-centromeric instability-facial anomalies syndrome 1. Human ortholog(s) of this gene implicated in several diseases, including autoimmune disease (multiple); carcinoma (multiple); facioscapulohumeral muscular dystrophy 4; immunodeficiency-centromeric instability-facial anomalies syndrome 1; and thymoma. Orthologous to human DNMT3B (DNA methyltransferase 3 beta).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.